Premium
A three‐base deletion removing a leucine residue in a leucine‐rich repeat of platelet glycoprotein Ibα associated with a variant of Bernard‐Soulier syndrome (Nancy I)
Author(s) -
Salle Corinne,
Baas MarieJeanne,
Lanza Franccois,
Schwartz Agnegs,
Hanau Daniel,
Chevalier Jerotme,
Gachet Christian,
Briquel MarieElisabeth,
Cazenave JeanPierre
Publication year - 1995
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/j.1365-2141.1995.tb03316.x
Subject(s) - bernard–soulier syndrome , glycoprotein ib , leucine , platelet membrane glycoprotein , von willebrand factor , platelet glycoprotein gpib ix complex , glycoprotein , von willebrand disease , leucine rich repeat , genetics , platelet , biology , microbiology and biotechnology , biochemistry , chemistry , receptor , amino acid , immunology
Summary. Leucine‐rich repeats are conserved structural motifs present in the four components of the human platelet glycoprotein Ib/IX/V complex receptor for the adhesive protein von Willebrand factor. The absence or abnormality of this complex is responsible for Bernard‐Soulier disease, an autosomal recessive bleeding disorder. We report a deletion of leucine 179, located in a highly conserved position of the seventh leucine‐rich repeat of GPIbα, found in a variant form of Bernard‐Soulier disease (Bernard‐Soulier Nancy I). Three affected siblings of a family were characterized by absence of ristocetin‐induced platelet agglutination, although ADP aggregation was normal. Flow cytometry studies showed detectable amounts of all four members of the GPIb/IX/V complex on the surface of the patients’ platelets. Western blotting revealed normal levels of GPIX, decreased levels of GPIbβ and GPV, and <1% of GPIbα. RT‐PCR studies showed the presence of mRNA coding for GPIbα. GPIbβ, GPIX and GPV. Sequencing showed a three‐base deletion which results in the absence of a leucine residue, highly conserved across the seven leucine‐rich repeats of GPIbα and also within the other members of the leucine‐rich glycoprotein family. The absence of the leucine 179 in a patient's GPIbα is believed to cause a conformational change in the protein which would account for the lack of binding of most of the MoAbs tested and would be responsible for the absence of von Willebrand factor binding. These results point to the leucine‐rich region of GPIbα as being required for the correct exposure of the von Willebrand binding site as well as for the correct assembly and stability of the GPIb IX V complex on the platelet surface.